Literature DB >> 2446636

A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis).

H Mabuchi1, I Michishita, M Takeda, H Fujita, J Koizumi, R Takeda, S Takada, M Oonishi.   

Abstract

We describe a new low density lipoprotein (LDL) apheresis system using dextran sulfate cellulose column in an automated column regenerating unit (LDL continuous apheresis). Two columns containing 150 ml of dextran sulfate cellulose were used, and the whole extracorporeal circulation was about 400 ml in volume. After 600 ml of plasma was adsorbed into the first column, the second column was used as an adsorbent and meanwhile the first column was regenerated. Thus, the 2 columns were used alternately without losing the potency of the columns. As the apparatus was automatically controlled by a computerized unit, no extra manipulation is necessary compared with the conventional single-column method. By treating 4-5 liters of plasma, non-high density lipoprotein (HDL)-cholesterol levels decreased by 63-71%, and HDL-cholesterol levels remained unchanged. Thus, this new method of LDL apheresis can safely reduce LDL-cholesterol to any desired level and will be applicable for the treatment of child and adult family hypercholesterolemic patients with severe coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446636     DOI: 10.1016/0021-9150(87)90089-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

1.  LDL-apheresis therapy.

Authors:  Patrick M Moriarty
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-08

2.  Low-density lipoprotein apheresis reduces platelet factor 4 on the surface of platelets: a possible protective mechanism against heparin-induced thrombocytopenia and thrombosis.

Authors:  Yvette C Tanhehco; Ann H Rux; Bruce S Sachais
Journal:  Transfusion       Date:  2010-10-26       Impact factor: 3.157

3.  Antioxidant status of hypercholesterolemic patients treated with LDL apheresis.

Authors:  S Lepage; D Bonnefont-Rousselot; E Bruckert; B Bourely; M C Jaudon; J Delattre; U Assogba
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

4.  The effect of plasma low density lipoprotein apheresis on the hepatic secretion of biliary lipids in humans.

Authors:  C G Hillebrant; B Nyberg; K Einarsson; M Eriksson
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

Review 5.  Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances.

Authors:  Claudia Stefanutti; Gilbert R Thompson
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

6.  Long-term experience with extracorporeal low-density lipoprotein cholesterol removal by dextran sulfate cellulose adsorption.

Authors:  P Schulzeck; C J Olbricht; K M Koch
Journal:  Clin Investig       Date:  1992-02

7.  Plasminogen activator inhibitor-1 removal using dextran sulphate columns. Evidence of PAI-1 homeostasis.

Authors:  Vincent M G Maher; Yuri Kitano; Clare Neuwirth; Graham J Davies; Attilio Maseri; Gilbert R Thompson; Felicita Andreotti
Journal:  J Thromb Thrombolysis       Date:  2008-07-30       Impact factor: 2.300

8.  Treatment with a combination of low-density lipoprotein aphaeresis and pravastatin of a patient with drug-resistant nephrotic syndrome due to focal segmental glomerulosclerosis.

Authors:  M Hattori; K Ito; H Kawaguchi; T Tanaka; R Kubota; M Khono
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

9.  Comparative long-term experience with immunoadsorption and dextran sulfate cellulose adsorption for extracorporeal elimination of low-density lipoproteins.

Authors:  W Knisel; M Pfohl; M Müller; I Besenthal; A di Nicuolo; W Voelker; T Risler; M Eggstein
Journal:  Clin Investig       Date:  1994-09

Review 10.  LDL-apheresis: technical and clinical aspects.

Authors:  Rolf Bambauer; Carolin Bambauer; Boris Lehmann; Reinhard Latza; Ralf Schiel
Journal:  ScientificWorldJournal       Date:  2012-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.